Medulloblastoma: tumor biological and clinical perspectives Henry S. FriedmanW. fnJerry OakesDarell D. Bigner Review Pages: 1 - 15
2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells Ka-Ho WongC. Anne WallenKenneth T. Wheeler Laboratory Investigations Pages: 17 - 25
Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures François DozMichael E. BerensMark L. Rosenblum Laboratory Investigations Pages: 27 - 35
Hyperthermic potentiation of BCNU toxicity in BCNU-resistant human glioma cells Vasco F. Da SilvaMark FeeleyGijsbert P. Raaphorst Laboratory Investigations Pages: 37 - 41
Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression Ann F. ChambersGeorgetta H. DenhardtJ. Gregory Cairncross Laboratory Investigations Pages: 43 - 48
Isolation and characterization of microvessels from normal brain and brain tumors Daniel L. SilbergeldFrancis Ali-Osman Laboratory Investigations Pages: 49 - 55
Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors Brian J. CordenLewis C. StraussPeter C. Phillips Clinical Studies Pages: 57 - 63
Corynebacterium JK: A new pathogen in ventriculostomy infections Vicki A. MorrisonEric L. WeinshelSharon D. Luikart Clinical Studies Pages: 65 - 69
Anti-histone antibodies in subacute sensory neuropathy Marc MonestierThomas M. FasyFrank S. Lieberman Clinical Studies Pages: 71 - 75
Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission Michael L. GruberFred H. Hochberg OriginalPaper Pages: 77 - 79